Browse by Academic Unit (A-Z)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators Name | Item Type
Jump to: B | D | H | M | R | S | T | V
Number of items at this level: 13.


Bogaerts, J, Sydes, MR, Keat, N et al. (43 more authors) (2014) Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. European journal of cancer. ISSN 0014-2964


Drummond, MW, Pocock, C, Boissinot, M et al. (9 more authors) (2014) A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia. Leukemia, 28 (7). 1570 - 1572. ISSN 0887-6924


Hennig, IM, Naik, JD, Brown, S et al. (8 more authors) (2008) Severe sequence-specific toxicity when capecitabine is given after fluorouracil and leucovorin. Journal of Clinical Oncology, 26 (20). 3411 - 3417. ISSN 0732-183X


Maughan, TS, Meade, AM, Adams, RA et al. (22 more authors) (2014) A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine? British Journal of Cancer, 110 (9). 2178 - 2186. ISSN 0007-0920

Middleton, G, Brown, S, Lowe, C et al. (17 more authors) (2013) A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO). European Journal of Cancer, 49 (16). 3507 - 3516. ISSN 0959-8049

Mukherjee, S, Hurt, CN, Gwynne, S et al. (16 more authors) (2015) NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer, 15 (1). ARTN 48. ISSN 1471-2407


Rosmarin, D, Palles, C, Church, D et al. (41 more authors) (2014) Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. Journal of Clinical Oncology, 32 (10). 1031 - 1039. ISSN 0732-183X


Seymour, MT, Brown, SR, Middleton, G et al. (18 more authors) (2013) Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial. The Lancet Oncology, 14 (8). 749 - 759. ISSN 1470-2045

Smith, CG, West, H, Harris, R et al. (12 more authors) (2013) Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis. Journal of the National Cancer Institute, 105 (16). 1249 - 1253. ISSN 0027-8874


Taylor, S, Harley, C, Campbell, LJ et al. (6 more authors) (2010) Discussion of emotional and social impact of cancer during outpatient oncology consultations. Psycho-Oncology, 20 (3). 242 - 251 . ISSN 1099-1611


Varley, C.L., Stahlschmidt, J., Lee, W.C. et al. (5 more authors) (2004) Role of PPAR? and EGFR signalling in the urothelial terminal differentiation programme. Journal of Cell Science, 117 (10). pp. 2029-2036. ISSN 0021-9533

Velikova, G, Keding, A, Harley, C et al. (6 more authors) (2010) Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial. European Journal of Cancer, 46 (13). 2381 - 2388 . ISSN 1879-0852

Venderbosch, S, Nagtegaal, ID, Maughan, TS et al. (13 more authors) (2014) Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN and FOCUS studies. Clinical Cancer Research, 20. 5322 - 5330. ISSN 1078-0432

This list was generated on Wed Oct 26 03:38:46 2016 BST.